# Hélène Blons

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/helene-blons/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11,067 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 57 |
| i10-index | 124 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5060265115 |
| ORCID iD | 0000-0002-0572-8426 |
| Works | 341 |

## Researcher papers

- [Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)](https://scholariq.org/papers/routine-molecular-profiling-of-patients-with-advanced-non-small-cell-lung-cancer/)
- [Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives](https://scholariq.org/papers/lung-cancer-that-harbors-an-i-her2-i-mutation-epidemiologic-characteristics-and/)
- [Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients](https://scholariq.org/papers/multiplex-picodroplet-digital-pcr-to-detect-kras-mutations-in-circulating-dna/)
- [Transplantation of Human Embryonic Stem Cell–Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction](https://scholariq.org/papers/transplantation-of-human-embryonic-stem-cell-derived-cardiovascular-progenitors/)
- [<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma](https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/)
- [Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network](https://scholariq.org/papers/rare-egfr-exon-18-and-exon-20-mutations-in-non-small-cell-lung-cancer-on-10-117/)
- [Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis](https://scholariq.org/papers/detection-of-free-circulating-tumor-associated-dna-in-plasma-of-colorectal/)
- [Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial](https://scholariq.org/papers/oxaliplatin-fluorouracil-and-leucovorin-with-or-without-cetuximab-in-patients/)
- [Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)](https://scholariq.org/papers/early-evaluation-of-circulating-tumor-dna-as-marker-of-therapeutic-efficacy-in/)
- [SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations](https://scholariq.org/papers/slc26a4-gene-is-frequently-involved-in-nonsyndromic-hearing-impairment-with/)
- [Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study](https://scholariq.org/papers/resistance-mechanisms-to-osimertinib-in-egfr-mutated-advanced-non-small-cell/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.